VIGNOLA MARK J. (Chief Financial Officer) sold 9.8% of their position (10K shares) of TERNS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $110.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/12/2024ACC: 0001562180-24-006794
Officer· Chief Financial Officer
Since Feb 2021
-10K
Net shares
Net seller
$110.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$5.36
Trade value
$53.60K
% of position
10.9%
9/10/2024
91.94K→101.94K
Common Stock
Direct
Shares
−10K
Price / share
$11.00
Trade value
$110K
% of position
9.8%
9/10/2024
101.94K→91.94K
Total
Net shares
+0.00
Net value
-$56.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2024 | M · Option Exercise | +10K | $5.36 | $53.60K | 10.9% | 91.94K | 101.94K |
| Common Stock Direct | 9/10/2024 | S · Sale | −10K | $11.00 | $110K | 9.8% | 101.94K | 91.94K |
| Total | +0.00 | -$56.40K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
5.36
Held after
55K
Exercisable
—
9/10/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 9/10/2024 | M · Option Exercise | −10K | 5.36 | — | 55K |